ԴՕՆԱ

main_info

  • trade_name:
  • ԴՕՆԱ
  • dosage:
  • 1500մգ, (20), (30) փաթեթիկներ1500մգ, (20), (30) փաթեթիկներ
  • pharmaceutical_form:
  • դեղափոշի ներքին ընդունման լուծույթի
  • prescription_type:
  • Դեղատոմսով
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic

documents

localization

  • country:
  • ԴՕՆԱ
    አርሜኒያ
  • language:
  • አማርኛ

other_info

status

  • source:
  • Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում - Armenia
  • last_update:
  • 31-05-2018

29-3-2019

Food supplements for joint problems should be avoided by certain populations

Food supplements for joint problems should be avoided by certain populations

In France, the use of dietary supplements containing glucosamine and/or chondroitin sulfate, presented as being able to contribute to joint comfort, has increased significantly. Adverse reactions potentially associated with the consumption of these food supplements have been identified by the ANSES nutrivigilance scheme. For this reason, the Agency conducted an assessment to identify the potential risks associated with taking these products.

France - Agence Nationale du Médicament Vétérinaire

1-4-2019


Withdrawn application: Equitend, polycarboxymethyl glucose sulfate acetate, Date of withdrawal: 05/11/2018, Initial authorisation

Withdrawn application: Equitend, polycarboxymethyl glucose sulfate acetate, Date of withdrawal: 05/11/2018, Initial authorisation

Withdrawn application: Equitend, polycarboxymethyl glucose sulfate acetate, Date of withdrawal: 05/11/2018, Initial authorisation

Europe - EMA - European Medicines Agency